• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Arteris Inc.

    12/11/25 4:18:27 PM ET
    $AIP
    Semiconductors
    Technology
    Get the next $AIP alert in real time by email
    8-K
    false 0001667011 0001667011 2025-12-10 2025-12-10
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of Report (date of earliest event reported): December 10, 2025

     

     

    ARTERIS, INC.

    (Exact name of Registrant, as specified in its charter)

     

     

     

    Delaware   001-40960   27-0117058

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification Number)

    900 E. Hamilton Ave., Suite 300

    Campbell, CA 95008

    (Address of principal executive offices, including Zip code)

    Registrant’s telephone number, including area code: (408) 470-7300

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange

    on which registered

    Common Stock, $0.001 par value per share   AIP   The Nasdaq Stock Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 1.01 Entry into a Material Definitive Agreement.

    Agreement and Plan of Merger and Reorganization

    On December 10, 2025, Arteris, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Cabernet Merger Sub I, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub I”), Arteris Security, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company (“Merger Sub II”), Cycuity, Inc., a Delaware corporation (“Cycuity”), and Shareholder Representative Services LLC, solely in its capacity as Holder Representative, as defined in the Merger Agreement.

    The Merger Agreement provides for the acquisition of Cycuity by the Company through a two-step merger process. First, Merger Sub I will merge with and into Cycuity, with Cycuity as the surviving corporation (the “First Merger”). Immediately following the First Merger, Cycuity will merge with and into Merger Sub II, with Merger Sub II surviving as a wholly-owned subsidiary of the Company (the “Second Merger,” and together with the First Merger, the “Mergers”). The Merger Agreement contains customary representations, warranties, and covenants by the parties.

    Merger Consideration

    Pursuant to the terms of the Merger Agreement, the aggregate consideration to be paid by the Company is up to $45,000,000, consisting of:

     

      1.

    Closing Consideration

     

      •  

    $13,500,000 in cash.

     

      •  

    $19,500,000 in shares of the Company’s common stock, par value $0.001 per share. The number of shares to be issued will be based on the volume-weighted average price of the Company’s common stock for the 30 consecutive trading days preceding the second trading day prior to the closing date, subject to a collar mechanism (the “VWAP”).

     

      2.

    Earnout Consideration

     

      •  

    Up to an additional $12,000,000, payable in shares of the Company’s common stock converted at the VWAP, contingent upon Cycuity achieving certain specified bookings milestones for the 2026 calendar year.

    The closing consideration is subject to customary adjustments, including for Cycuity’s closing cash, indebtedness, transaction expenses, and a working capital adjustment. In addition, pursuant to the terms of the Merger Agreement, certain holders of Cycuity securities will receive cash instead of the Company’s common stock.

    Escrow and Indemnification

    At closing, the Company will deposit into escrow a portion of the merger consideration, consisting of:

     

      •  

    An indemnity escrow amount of $3,300,000 in a mix of cash and the Company’s common stock to be held for 12 months to partially secure indemnification claims under the Merger Agreement.

     

      •  

    An adjustment escrow amount of $330,000 in cash to secure post-closing purchase price adjustments.

    Closing Conditions and Termination

    The consummation of the Mergers is subject to customary closing conditions, including, among others: (i) the approval of the Merger Agreement by Cycuity’s stockholders; (ii) the absence of any law or order prohibiting the Mergers; (iii) the accuracy of the parties’ respective representations and warranties; (iv) the performance by the parties of their respective covenants; and (v) the absence of a material adverse effect on Cycuity.

     


    The Merger Agreement also contains customary termination rights for both the Company and Cycuity.

    The foregoing summary of the Merger Agreement does not purport to be complete and is qualified in its entirety by the full text of the Merger Agreement, which is attached hereto as Exhibit 2.1 and is incorporated by reference herein.

     

    Item 9.01

    Financial Statements and Exhibits.

    (d) Exhibits

     

    Exhibit
    No.
       Description
    2.1†    Agreement and Plan of Merger and Reorganization, dated as of December 10, 2025, by and among Arteris, Inc., Cabernet Merger Sub I, Inc., Arteris Security, LLC, Cycuity, Inc., and Shareholder Representative Services LLC, solely in its capacity as Holder Representative.
    104    Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

     

    †

    Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date: December 11, 2025

     

    By:  

    /s/ Nicholas B. Hawkins

    Name:   Nicholas B. Hawkins
    Title:  

    Vice President and Chief Financial Officer

    (Principal Financial and Accounting Officer)

    3

    Get the next $AIP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIP

    DatePrice TargetRatingAnalyst
    8/6/2025$12.00 → $15.00Buy
    TD Cowen
    9/1/2023$11.00 → $12.00Outperform
    TD Cowen
    3/4/2022$32.00 → $23.00Outperform
    Cowen
    11/22/2021$27.00Outperform
    Northland Capital
    11/22/2021$24.00Market Perform
    BMO Capital Markets
    11/22/2021$30.00Outperform
    Cowen
    11/22/2021$33.00Buy
    Jefferies
    11/22/2021$35.00Buy
    Rosenblatt
    More analyst ratings

    $AIP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Arteris to Expand Portfolio with Acquisition of Cycuity, a Leader in Semiconductor Cybersecurity Assurance

    CAMPBELL, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating semiconductor creation in the AI era, today announced it has entered into a definitive agreement to acquire Cycuity, Inc., a leading provider of semiconductor cybersecurity assurance. The addition of Cycuity's technology and expertise strengthens Arteris' product portfolio, enabling chip designers to understand and improve data movement security in chiplets and SoCs. This pending acquisition addresses a growing industry concern about the increasing volume of sophisticated cyberattacks targeting the vast amounts of unsecured data moving through semiconductors, fro

    12/11/25 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris Selected by Black Sesame Technologies for Next Generation of Intelligent Driving Silicon

    CAMPBELL, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating semiconductor creation in the AI era, today announced that Black Sesame Technologies has licensed Arteris' Ncore 3 cache coherent network-on-chip (NoC) IP and FlexNoC 5 non-coherent NoC IP with physical awareness. Arteris technology will be used to optimize on-chip connectivity and data movement for SoCs and SoC-based solutions that deliver full-stack autonomous driving capabilities for the next generation of intelligent vehicles. Black Sesame Technologies addresses the needs of today's automotive industry with a broad portfolio that spans high-performance SoCs

    12/2/25 9:00:00 AM ET
    $AIP
    Semiconductors
    Technology

    Blaize Deploys Arteris NoC IP to Power Scalable, Energy-Efficient Edge AI Solutions

    CAMPBELL, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating semiconductor creation in the AI era, today announced that Blaize has adopted FlexNoC 5 interconnect IP to enhance the performance and scalability of the Blaize AI Platform, a programmable, energy-efficient foundation for hybrid AI deployment models spanning edge and cloud infrastructure. The network-on-chip IP from Arteris enables efficient AI data movement, high-performance computing, and reductions in power consumption and time-to-market. Highly configurable and performance-optimized, Arteris FlexNoC empowers Blaize to advance its platform architecture to meet

    11/11/25 9:00:00 AM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Moll Laurent R sold $340,112 worth of shares (17,937 units at $18.96), decreasing direct ownership by 7% to 257,222 units (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    12/11/25 5:05:54 PM ET
    $AIP
    Semiconductors
    Technology

    Director Viana Antonio J sold $360,194 worth of shares (20,000 units at $18.01) (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    12/10/25 4:11:50 PM ET
    $AIP
    Semiconductors
    Technology

    VP and Chief Financial Officer Hawkins Nicholas B. sold $12,661 worth of shares (721 units at $17.56), decreasing direct ownership by 0.77% to 92,431 units (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    12/10/25 4:11:31 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Arteris with a new price target

    TD Cowen reiterated coverage of Arteris with a rating of Buy and set a new price target of $15.00 from $12.00 previously

    8/6/25 7:10:46 AM ET
    $AIP
    Semiconductors
    Technology

    TD Cowen reiterated coverage on Arteris with a new price target

    TD Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $12.00 from $11.00 previously

    9/1/23 7:31:29 AM ET
    $AIP
    Semiconductors
    Technology

    Cowen reiterated coverage on Arteris with a new price target

    Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $23.00 from $32.00 previously

    3/4/22 7:21:31 AM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    SEC Filings

    View All

    SEC Form S-3 filed by Arteris Inc.

    S-3 - Arteris, Inc. (0001667011) (Filer)

    12/11/25 4:41:42 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form 8-K filed by Arteris Inc.

    8-K - Arteris, Inc. (0001667011) (Filer)

    12/11/25 4:18:27 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form 144 filed by Arteris Inc.

    144 - Arteris, Inc. (0001667011) (Subject)

    12/8/25 4:34:07 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Financials

    Live finance-specific insights

    View All

    Arteris Announces Financial Results for the Third Quarter and Estimated Fourth Quarter and Updated Full Year 2025 Guidance

    CAMPBELL, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced financial results for the third quarter ended September 30, 2025 and provided estimated fourth quarter and updated full year 2025 guidance. "In the third quarter of 2025, we achieved another record with Annual Contract Value plus royalties of $74.9 million, up 24% year-over-year. In addition, we exited the quarter with $104.7 million in Remaining Performance Obligations, up 34% year-over-year and exceeding $100.0 million for the first time in our history," said K. Charles Janac, President and CEO of Ar

    11/4/25 4:06:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris to Announce Financial Results for the Third Quarter 2025 on Tuesday, November 4, 2025

    CAMPBELL, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating semiconductor creation, today announced it will release its financial results for the third quarter ended September 30, 2025, after market close on Tuesday, November 4, 2025. Management will host a conference call on Tuesday, November 4, 2025, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing: United States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865     Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A live webcast will be availabl

    10/23/25 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2025 Guidance

    CAMPBELL, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced financial results for the second quarter ended June 30, 2025 and provided estimated third quarter and updated full year 2025 guidance. "In the second quarter of 2025, we achieved record Annual Contract Value plus royalties of $69.1 million and exited the quarter with $99.3 million in Remaining Performance Obligations, with the latter representing a year-over-year increase of 28%," said K. Charles Janac, President and CEO of Arteris. "Looking ahead, we remain confident in Arteris' long-term growth opp

    8/5/25 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Arteris Inc.

    SC 13G/A - Arteris, Inc. (0001667011) (Subject)

    11/13/24 4:32:26 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form SC 13G filed by Arteris Inc.

    SC 13G - Arteris, Inc. (0001667011) (Subject)

    6/27/24 3:46:24 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form SC 13G/A filed by Arteris Inc. (Amendment)

    SC 13G/A - Arteris, Inc. (0001667011) (Subject)

    1/24/24 4:05:55 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Leadership Updates

    Live Leadership Updates

    View All

    Joachim Kunkel Joins Arteris Board of Directors

    CAMPBELL, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that Joachim Kunkel will join its Board of Directors. Mr. Kunkel most recently served as the General Manager of the Intellectual Property (IP) business unit at Synopsys where he grew Synopsys' IP revenue to over $1.5 billion, making Synopsys the second largest semiconductor IP company in the world. With three decades of experience at Synopsys, Mr. Kunkel brings a wealth of knowledge and leadership to Arteris. Prior to joining Synopsys, Joachim Kunkel co-founded and served as managing director of CADIS GmbH, where

    9/16/24 5:00:00 PM ET
    $AIP
    Semiconductors
    Technology